Back
Beam Therapeutics, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
64
BEAM
Beam Therapeutics, Inc.
Last Price:
$26.78
Seasonality Move:
6.45%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBeam Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 15% based on the past 5 years of stock performance.
-
Beam Therapeutics, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Beam Therapeutics, Inc. Stock Undervalued?The current Beam Therapeutics, Inc. [BEAM] share price is $26.83. The Score for BEAM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
BEAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Beam Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 15% based on the past 5 years of stock performance.
Beam Therapeutics, Inc. Stock Rating
Buy
64
Beam Therapeutics, Inc. (BEAM)
is a Buy
Is Beam Therapeutics, Inc. overpriced?
-
Beam Therapeutics, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Beam Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com
52-Week Data
52-Week High:
35.25
52-Week Low:
13.53
Prediction Charts
Market Cap:
2.7B
Price in USD:
26.83
Volume:
1.9M
Beta:
1.85
Technical Analysis
SMA50:
25.14
SMA100:
22.57
SMA200:
20.99
52-Wk Change:
-3.94%
Stock Predictions
-
Is Beam Therapeutics, Inc. stock public?Yes, Beam Therapeutics, Inc. is a publicly traded company.
-
What is the Beam Therapeutics, Inc. stock quote today?The Beam Therapeutics, Inc. stock price is 26.83 USD today.
-
How to buy Beam Therapeutics, Inc. stock online?You can buy Beam Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-25 | 23.49 | 24.69 | 25.25 | 23.33 |
| Nov-26 | 24.97 | 25.03 | 25.26 | 24.38 |
| Nov-28 | 25.11 | 25.33 | 25.56 | 24.57 |
| Dec-1 | 24.78 | 24.05 | 25.24 | 24.00 |
| Dec-2 | 24.03 | 23.37 | 24.38 | 23.34 |
| Dec-3 | 23.48 | 26.74 | 26.85 | 23.30 |
| Dec-4 | 26.39 | 28.91 | 29.16 | 26.35 |
| Dec-5 | 28.79 | 27.09 | 28.87 | 27.00 |
| Dec-8 | 27.55 | 27.10 | 28.14 | 26.77 |
| Dec-9 | 26.66 | 26.48 | 27.13 | 26.12 |
| Dec-10 | 26.32 | 27.40 | 28.28 | 25.86 |
| Dec-11 | 27.25 | 27.51 | 28.09 | 27.00 |
| Dec-12 | 27.50 | 27.36 | 27.91 | 26.83 |
| Dec-15 | 27.47 | 26.83 | 28.10 | 26.56 |
Beam Therapeutics, Inc. Earnings
Beam Therapeutics, Inc. Earnings Report: Per Share Beam Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Beam Therapeutics, Inc. Forecast Revenue Growth
Beam Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.17 per share.
* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.